Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SINTX Technologies Buyback Yield % Historical Data
* Premium members only.
The historical data trend for SINTX Technologies's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1110 vs ALRTF, CODX, PMI: Buyback Yield % Comparison
For the Medical Devices subindustry, SINTX Technologies's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SINTX Technologies Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where SINTX Technologies's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SINTX Technologies (FRA:1110) has a Buyback Yield % of -47.28 as of Jul. 24, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on SINTX Technologies and its competitors. According to the industry distribution chart, SINTX Technologies ranks #308 out of 349 companies in the Medical Devices & Instruments industry, placing it in the top 88.3%.
Is SINTX Technologies' Buyback Yield % too high?
SINTX Technologies' current Buyback Yield % is -47.28. Based on the distribution chart, SINTX Technologies ranks #308 out of 349 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SINTX Technologies has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does SINTX Technologies' Buyback Yield % compare to ALRTF and CODX?
According to the Medical Devices & Instruments industry distribution chart, SINTX Technologies ranks #308 out of 349 companies for Buyback Yield %. This places SINTX Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on SINTX Technologies and its competitors. SINTX Technologies's current Buyback Yield % is -47.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SINTX Technologies stock overvalued right now?
SINTX Technologies (FRA:1110) has a current Buyback Yield % of -47.28. The stock's GF Value™ is €1.27, compared to a current price of €13.00 — trading 923.6% above its estimated fair value. The current Buyback Yield % is -47.28. SINTX Technologies' overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For SINTX Technologies (FRA:1110), the current Buyback Yield % is -47.28 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SINTX Technologies (FRA:1110) Overvalued in 2026?
Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued.
The current stock price of €13.00 is trading 923.6% above its estimated GF Value™ of €1.27.
Key valuation signals for FRA:1110:
Buyback Yield %: -47.28
GF Value™: €1.27 vs. price of €13.00 (923.6% above fair value)
No single metric tells the full story. See the FRA:1110 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
27GF Score
Get the complete analysis for FRA:1110
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1110 has been successfully added to your 
